| Australian Neuroscience Society - 30th Annual Meeting and Australian Physiological Society - 50th Anniversary Meeting. | |
| | |
MedLine Citation:
|
PMID: 20373243 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The joint 30th Annual Meeting of the Australian Neuroscience Society and the 50th Anniversary Meeting of the Australian Physiological Society, held in Sydney, included topics covering new developments in the fields of neuroscience and physiology. This conference report highlights selected presentations on potential treatments for neuropathic pain, mood disorders and Alzheimer's disease. Investigational drugs discussed include 4-ACPBPA (Circadian Technologies Ltd/University of Sydney) and F-15599 (Pierre Fabre SA). |
| | |
Authors:
|
Anthony J Hannan |
Related Documents
:
|
17774593 - Geological society of america meeting: geologists pursue solar system's oldest relics. 20025393 - Abstracts of the 2009 csbbcs annual meeting. 11338163 - Preventing and resolving ethical conflicts: more help for policy makers. |
Publication Detail:
|
Type: Congresses |
Journal Detail:
|
Title: IDrugs : the investigational drugs journal Volume: 13 ISSN: 2040-3410 ISO Abbreviation: IDrugs Publication Date: 2010 Apr |
Date Detail:
|
Created Date: 2010-04-07 Completed Date: 2010-09-14 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100883655 Medline TA: IDrugs Country: England |
Other Details:
|
Languages: eng Pagination: 201-3 Citation Subset: IM |
Affiliation:
|
University of Melbourne, Howard Florey Institute, Florey Neuroscience Institutes, Royal Parade, Parkville, VIC, Australia. anthony.hannan@florey.edu.au |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Alzheimer Disease
/
drug therapy,
metabolism Animals Australia Brain / drug effects, metabolism Central Nervous System Depressants / adverse effects, pharmacology, therapeutic use Cognition / drug effects Conotoxins / therapeutic use Enzyme Inhibitors / pharmacology, therapeutic use Humans Lipid Metabolism / drug effects Mood Disorders / drug therapy, metabolism Neurology* Pain / drug therapy Physiology* Societies, Medical* Sphingolipids / biosynthesis |
| Chemical | |
Reg. No./Substance:
|
0/Central Nervous System Depressants; 0/Conotoxins; 0/Enzyme Inhibitors; 0/Sphingolipids |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effects of body weight, height, and rib cage area moment of inertia on blunt chest impact response.
Next Document: Biomarkers - SMi's Third Summit Discovery, Validation & Qualification.